These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 9013701

  • 1. Regulation of NF-kappaB and HIV-1 LTR activity in mouse L cells by ultraviolet radiation: LTR trans-activation in a nonirradiated genome in heterokaryons.
    Miller SC, Taylor A, Watanabe K, Mok K, Torti FM.
    Exp Cell Res; 1997 Jan 10; 230(1):9-21. PubMed ID: 9013701
    [Abstract] [Full Text] [Related]

  • 2. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
    Li JJ, Westergaard C, Ghosh P, Colburn NH.
    Cancer Res; 1997 Aug 15; 57(16):3569-76. PubMed ID: 9270030
    [Abstract] [Full Text] [Related]

  • 3. X-rays-induced secretion of cellular factor(s) that enhance(s) HIV-1 promoter transcription in various non-irradiated transfected cell lines.
    Faure E.
    Cell Mol Biol (Noisy-le-grand); 1998 Dec 15; 44(8):1275-92. PubMed ID: 9874515
    [Abstract] [Full Text] [Related]

  • 4. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function.
    Kameoka M, Tanaka Y, Ota K, Itaya A, Yoshihara K.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):285-9. PubMed ID: 10448106
    [Abstract] [Full Text] [Related]

  • 5. A quantitative bioassay for HIV-1 gene expression based on UV activation: effect of glycyrrhizic acid.
    Cherng JM, Lin HJ, Hsu YH, Hung MS, Lin JC.
    Antiviral Res; 2004 Apr 19; 62(1):27-36. PubMed ID: 15026199
    [Abstract] [Full Text] [Related]

  • 6. Glucocorticoid can reduce the transcriptional activation of HIV-1 promoter through the reduction of active NF-kappaB.
    Kurata Si, Yamamoto N.
    J Cell Biochem; 1999 Nov 19; 76(1):13-9. PubMed ID: 10580996
    [Abstract] [Full Text] [Related]

  • 7. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.
    Virology; 2000 Sep 01; 274(2):262-77. PubMed ID: 10964770
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
    Zhang JL, Sharma PL, Crumpacker CS.
    Virology; 2000 Mar 15; 268(2):251-63. PubMed ID: 10704334
    [Abstract] [Full Text] [Related]

  • 9. Mood-enhancing antidepressant St. John's wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light.
    Taher MM, Lammering GM, Hershey CM, Valerie KC.
    IUBMB Life; 2002 Dec 15; 54(6):357-64. PubMed ID: 12665247
    [Abstract] [Full Text] [Related]

  • 10. Optimal NF kappa B mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals.
    Ginn-Pease ME, Whisler RL.
    Biochem Biophys Res Commun; 1996 Sep 24; 226(3):695-702. PubMed ID: 8831677
    [Abstract] [Full Text] [Related]

  • 11. Dual activity of pyrrolidine dithiocarbamate on kappaB-dependent gene expression in U937 cells: II. Regulation by tumour necrosis factor-alpha.
    Watanabe K, Kazakova I, Furniss M, Miller SC.
    Cell Signal; 1999 May 24; 11(5):371-83. PubMed ID: 10376811
    [Abstract] [Full Text] [Related]

  • 12. The Epstein-Barr virus DNA polymerase transactivates the human immunodeficiency virus type 1 5' long terminal repeat.
    Lin JC.
    Biochem Biophys Res Commun; 1993 Aug 31; 195(1):242-9. PubMed ID: 8395825
    [Abstract] [Full Text] [Related]

  • 13. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M, Rimessi P, Sabbioni S, Caputo A, Balboni PG, Gualandri R, Manservigi R, Grossi MP, Barbanti-Brodano G.
    Biotechniques; 1991 Mar 31; 10(3):344-53. PubMed ID: 1829615
    [Abstract] [Full Text] [Related]

  • 14. Gene activation mediated by protein kinase C in human macrophage and teratocarcinoma cells expressing aminoglycoside phosphotransferase activity.
    Maio JJ, Brown FL.
    J Cell Physiol; 1991 Dec 31; 149(3):548-59. PubMed ID: 1660486
    [Abstract] [Full Text] [Related]

  • 15. Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kappaB-dependent pathway.
    Sun J, Bergeron M, Barbeau B, Boivin G, Tremblay MJ.
    Clin Immunol; 2005 Feb 31; 114(2):190-8. PubMed ID: 15639653
    [Abstract] [Full Text] [Related]

  • 16. NF-kappaB activation Is delayed in mouse L929 cells infected with interferon suppressing, but not inducing, vesicular stomatitis virus strains.
    Boulares AH, Ferran MC, Lucas-Lenard J.
    Virology; 1996 Apr 01; 218(1):71-80. PubMed ID: 8615043
    [Abstract] [Full Text] [Related]

  • 17. Effects of gamma rays, ultraviolet radiation, sunlight, microwaves and electromagnetic fields on gene expression mediated by human immunodeficiency virus promoter.
    Libertin CR, Panozzo J, Groh KR, Chang-Liu CM, Schreck S, Woloschak GE.
    Radiat Res; 1994 Oct 01; 140(1):91-6. PubMed ID: 7938460
    [Abstract] [Full Text] [Related]

  • 18. Pyrrolidine dithiocarbamate-induced macrophage inflammatory protein-2 gene expression is NF-kappaB-independent but c-Jun-dependent in macrophage cell line RAW 264.7.
    Sohn WJ, Lee KW, Lee Y, Han JH, Choe YK, Kim DS, Kwon HJ.
    Mol Immunol; 2005 Jun 01; 42(10):1165-75. PubMed ID: 15829306
    [Abstract] [Full Text] [Related]

  • 19. UV-A-induced decrease in nuclear factor-kappaB activity in human keratinocytes.
    Djavaheri-Mergny M, Gras MP, Mergny JL, Dubertret L.
    Biochem J; 1999 Mar 15; 338 ( Pt 3)(Pt 3):607-13. PubMed ID: 10051429
    [Abstract] [Full Text] [Related]

  • 20. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
    Lodie TA, Reiner M, Coniglio S, Viglianti G, Fenton MJ.
    J Immunol; 1998 Jul 01; 161(1):268-76. PubMed ID: 9647233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.